HIGHFDA DRUG

Clonidine Transdermal System Recall Expanded for CGMP Deviations in 113,943 Cartons (2026)

Teva-affiliated Clonidine Transdermal System recalls 113,943 cartons after CGMP deviations. Unapproved raw material prompts recall. Stop use immediately and contact Teva or a healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
March 19, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
March 19, 2026
Hazard Level
HIGH
Brands
CLONIDINE TRANSDERMAL SYSTEM, Actavis Pharma, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CLONIDINE TRANSDERMAL SYSTEM, Actavis Pharma, Inc.
Product type
Transdermal Clonidine System
Model numbers
Lot: 100053892, Exp.: 04/2026, 100057899, Exp.: 05/2026, 100062704, Exp.: 02/2027.
UPC codes
0591-3508, 0591-3509, 0591-3510, 0591-3508-54, 0591-3508-04, 0591-3509-54, 0591-3509-04, 0591-3510-54 +1 more
Sizes
0.3 mg/day
Sold at
Multiple Retailers

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    March 19, 2026

  2. Reported by FDA DRUG

    April 15, 2026

  3. RecallRadar source check

    April 22, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: use of an unapproved raw material

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

About This Product

Clonidine transdermal system delivers clonidine through the skin to treat high blood pressure and certain other conditions.

Why This Is Dangerous

CGMP deviations indicate an unapproved raw material was used in production, which could affect drug quality and safety.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

No targeted injuries reported in the notice; however, the recall emphasizes quality control risk and potential unsafe drug product.

Practical Guidance

How to identify if yours is affected

  1. Check the carton for NDC 0591-3510-04 or 0591-3510-54
  2. Check expiration dates: Exp. 04/2026, Exp. 05/2026, Exp. 02/2027

Where to find product info

NDC numbers printed on carton and pouch; lot numbers on carton seals and foil packaging

What timeline to expect

No remediation timeframe provided in the notice; expect recall communications by Teva and FDA updates

If the manufacturer is unresponsive

  • Document all communications
  • Escalate to FDA consumer complaint if needed
  • Seek guidance from healthcare provider for alternative therapy

How to prevent similar issues

  • Verify CGMP compliance when purchasing drug products
  • Only use drug products from reputable pharmacies
  • Report any unusual drug quality issues to FDA/CPSc

Documentation advice

Keep recall notice, lot numbers, expiration dates, and any correspondence with manufacturer.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: CLONIDINE TRANSDERMAL SYSTEM. Manufacturer: Actavis Laboratories UT Inc., Salt Lake City, UT 84108. Distributor: Teva Pharmaceuticals USA, Inc. NDC 0591-3510-04 carton, 0591-3510-54 pouch. Quantity: 113,943 cartons. Form: 0.3 mg/day transdermal system. Pack: cartons of 4 Systems and 4 Adhesive Covers. Route: Rx only. Distribution: Within the U.S. Models/lot information in play: Lot 100053892 (Exp. 04/2026), Lot 100057899 (Exp. 05/2026), Lot 100062704 (Exp. 02/2027). Dates: Recall date 2026-03-19. Status: ACTIVE.

Reported Incidents

No specific injuries or incidents are described in the provided recall notice.

Key Facts

  • Cartons contain 4 System units and 4 Adhesive Covers
  • NDC 0591-3510-04 and NDC 0591-3510-54
  • Recall date: 2026-03-19; Status: ACTIVE

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANTELDERLYPETS
Injury Types
POISONINGELECTRICAL

Product Details

Model Numbers
Lot: 100053892
Exp.: 04/2026
100057899
Exp.: 05/2026
100062704
+1 more
UPC Codes
0591-3508
0591-3509
0591-3510
+6 more
Report Date
April 15, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls